Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
Clinical trial NCT03954132 · COMPLETED
Trial details
- NCT number
- NCT03954132
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-07
- Primary completion
- 2021-06-30
- Enrollment
- 469
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.